CESCA THERAPEUTICS INC. (46) | Uncategorized (9)

Recent Contracts

Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on May 27, 2022)
Engagement Letter, dated as of March 8, 2022, between ThermoGenesis Holding, Inc. and H.C. Wainright & Co., LLC (Filed With SEC on April 29, 2022)
Amendment No. 2 to At the Market Offering Agreement, dated February 3, 2022, by and between ThermoGenesis Holdings, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on February 3, 2022)
Amendment No. 1 to At The Market Offering Agreement, dated May 19, 2020, by and between ThermoGenesis Holdings, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on May 20, 2020)
Engagement Agreement, dated as of March 24, 2020, by and between ThermoGenesis Holdings, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 27, 2020)
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 24, 2020)
Stockholders Agreement, dated November 22, 2019, among ThermoGenesis Holdings, Inc., Healthbanks Biotech (USA) Inc. and ImmuneCyte Life Sciences Inc (Filed With SEC on November 27, 2019)
Right of First Refusal and Co-Sale Agreement, dated January 1, 2019, among CARTXpress Bio, Inc., ThermoGenesis Corp., Bay City Capital Fund V, L.P., and Bay City Capital Fund V... (Filed With SEC on January 4, 2019)
Amended and Restated Certificate of Incorporation of CARTXpress Bio, Inc (Filed With SEC on January 4, 2019)